Table 2.
Estrogen receptor and progesterone receptor statuses in cases pre- and post-neoadjuvant chemotherapy
| (ER, PR) pre-NAC | (ER, PR) post-NAC (n) | |||
|---|---|---|---|---|
|
|
||||
| (+, +) | (+, -) | (-, +) | (-, -) | |
| (+, +) | 43 | 8 | 11 | 3 |
| (+, -) | 9 | 27 | 6 | 10 |
| (-, +) | 9 | 7 | 15 | 15 |
| (-, -) | 3 | 8 | 3 | 90 |
NAC, neoadjuvant chemotherapy; ER, estrogen receptor; PR, progesterone receptor. n, numbers of patients.